4.6 Article

TTRAP Is a Novel Component of the Non-Canonical TRAF6-TAK1 TGF-β Signaling Pathway

Journal

PLOS ONE
Volume 6, Issue 9, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0025548

Keywords

-

Funding

  1. Hungarian Science Foundation (OTKA)/Norwegian Financial Mechanism [NNF78805]
  2. Janos Bolyai fellowship

Ask authors/readers for more resources

Transforming growth factor-beta (TGF-beta) principally relays its effects through the Smad pathway however, accumulating evidence indicate that alternative signaling routes are also employed by this pleiotropic cytokine. For instance recently, we have demonstrated that ligand occupied TGF-beta receptors can directly trigger the TRAF6-TAK1 signaling module, resulting in MAP kinase activation. Here we report identification of the adaptor molecule T TRAP as a novel component of this non-canonical TGF-beta pathway. We show that the protein associates with TGF-beta receptors and components of the TRAF6-TAK1 signaling module, resulting in differential regulation of TGF-beta activated p38 and NF-kappa B responses. Modulation of cellular TTRAP level affects cell viability in the presence of TGF-beta, suggesting that the protein is an important component of the TGF-beta induced apoptotic process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available